Andrea Manfrin

Andrea Manfrin

Auto-generated profile, based on publicly available information

Andrea Manfrin

Laboratory of Stem Cell Bioengineering, Institute of Bioengineering, School of Life Sciences and School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Cell
Verified
Journal Article
Closed access
MAMariaceleste Aragona
Mariaceleste Aragona
TPTito Panciera
Tito Panciera
AMAndrea Manfrin
Andrea Manfrin
SGStefano Giulitti
Stefano Giulitti
FMFederica Michielin
Federica Michielin
SPStefano Piccolo
Stefano Piccolo

16 November 2016 in Nature
Verified
Journal Article
Closed access
NGNikolce Gjorevski
Nikolce Gjorevski
NSNorman Sachs
Norman Sachs
AMAndrea Manfrin
Andrea Manfrin
SGSonja Giger
Sonja Giger
MBMaiia E. Bragina
Maiia E. Bragina
MLMatthias P. Lutolf
Matthias P. Lutolf

18 September 2018 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
GRGiuliana Rossi
Giuliana Rossi
AMAndrea Manfrin
Andrea Manfrin
MLMatthias Lutolf
Matthias Lutolf

23 March 2014 in Nature Cell Biology
Verified
Journal Article
Closed access
GSGiovanni Sorrentino
Giovanni Sorrentino
NRNaomi Ruggeri
Naomi Ruggeri
VSValeria Specchia
Valeria Specchia
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
MMMiguel Mano
Miguel Mano
GSGiannino Del Sal
Giannino Del Sal

1 June 2010 in Cell
Verified
Journal Article
Closed access
GMGraziano Martello
Graziano Martello
ARAntonio Rosato
Antonio Rosato
FFFrancesco Ferrari
Francesco Ferrari
AMAndrea Manfrin
Andrea Manfrin
MCMichelangelo Cordenonsi
Michelangelo Cordenonsi
SPStefano Piccolo
Stefano Piccolo

17 September 2018 in Nature Medicine
Verified
Journal Article
Open access
PDF file
FZFrancesca Zanconato
Francesca Zanconato
GBGiusy Battilana
Giusy Battilana
MFMattia Forcato
Mattia Forcato
LFLetizia Filippi
Letizia Filippi
LALuca Azzolin
Luca Azzolin
SPStefano Piccolo
Stefano Piccolo
Cancer cells rely on dysregulated gene expression. This establishes specific transcriptional addictions that may be therapeutically exploited. Yet, the mechanisms that are ultimately responsible for these addictions are poorly understood. Here, we investigated the transcriptional dependencies of transformed cells to the transcription factors YAP and TAZ. YAP/TAZ physically engage the general coactivator bromodomain-containing protein 4 (BRD4), dictating the genome-wide association of BRD4 to chromatin. YAP/TAZ flag a large set of enhancers with super-enhancer-like functional properties. YAP/TAZ-bound enhancers mediate the recruitment of BRD4 and RNA polymerase II at YAP/TAZ-regulated promoters, boosting the expression of a host of growth-regulating genes. Treatment with small-molecule inhibitors of BRD4 blunts YAP/TAZ pro-tumorigenic activity in several cell or tissue contexts, causes the regression of pre-established, YAP/TAZ-addicted neoplastic lesions and reverts drug resistance. This work sheds light on essential mediators, mechanisms and genome-wide regulatory elements that are responsible for transcriptional addiction in cancer and lays the groundwork for a rational use of BET inhibitors according to YAP/TAZ biology.